Tinnitus
Conditions
Interventions
Placebo group: Placebo was the control product, without active ingredients, made available through starch capsules, used by 15 participants, in their homes, according to the following method of use: t
Behavioural
Dietary supplement
F02.784.176
Sponsors
Universidade Federal de Santa Maria
Universidade Federal de Santa Maria
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age from 18 years; complaint of chronic tinnitus of at least six months; normal hearing or sensorineural hearing loss from degree to moderate
Exclusion criteria
Exclusion criteria: Neurological diseases; middle ear changes; hearing aid users; illiterate; coagulopaths
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the effectiveness of the experimental treatment, açaí extract with daily supplementation. It is expected to find attenuation of the discomfort with chronic tinnitus. Verified by the Visual Analogue Scale method, Minimum Masking Level, Tinnitus Handicap Inventory, Beck's Anxiety Inventory, The World Health Organization Quality of Life and oxidative stress biomarkers (Dichlorofluoresceinadiacetate, Lipid Peroxidation, Protein carbonylation). | — |
Secondary
| Measure | Time frame |
|---|---|
| Decreased discomfort with tinnitus was observed after treatment, for groups that contained supplementation with açaí, isolated açaí (Visual Analogue Scale p = 0.006; Tinnitus Handicap Inventory p = 0.006), açaí and counseling (Visual Analogue Scale p = 0.002; Tinnitus Handicap Inventory p = 0.014). Placebo Group decreased anxiety scores (p = 0.017) and Minimum Masking Level (p = 0.013). There were no statistically significant differences for quality of life and oxidative stress biomarkers. | — |
Countries
Brazil
Contacts
Public ContactPós graduação da Comunicação Humana
Universidade Federal de Santa Maria
Outcome results
None listed